Home » Authors » Trista Morrison

Articles by Trista Morrison

Encysive Tanks On Third PAH Approvable Letter For Thelin

June 19, 2007

By Trista Morrison

NewCo News: Tempo Hurries To Target Nanoparticle Combo Drugs

June 18, 2007

By Trista Morrison

NewCo News: Tempo Hurries To Target Nanoparticle Combo Drugs

June 18, 2007

By Trista Morrison

Optimistic Neurocrine Resubmits NDA For Insomnia Drug Indiplon

June 14, 2007

By Trista Morrison

Optimistic Neurocrine Resubmits NDA For Insomnia Drug Indiplon

June 14, 2007

By Trista Morrison

Coley Acquires TLR7 And TLR8 Programs From 3M For $20M

June 13, 2007

By Trista Morrison

Coley Acquires TLR7 And TLR8 Programs From 3M For $20M

June 13, 2007

By Trista Morrison

Acadia Starts First Phase III For Pimavanserin In Parkinson's

June 12, 2007

By Trista Morrison

Acadia Starts First Phase III For Pimavanserin In Parkinson's

June 12, 2007

By Trista Morrison

NewCo News: Viamet Gets $4 Million Series A For Targeting Metalloenzymes

June 11, 2007

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...